VICTORIA, Sept. 22, 2016 /CNW/ - Emerald Health
Therapeutics Inc. (TSXV: EMH) ("Therapeutics") is pleased to
announced that its wholly owned subsidiary, Emerald Health
Botanicals Inc. ("Botanicals"), has launched its initial three
cannabis oil products - THCA oil, THC oil, and THC:CBD oil.
Our cannabis oils are whole plant cannabis extracts that deliver
the benefits of cannabinoids orally. Oils are easily ingested and
allow for more accurate dosing without the need for inhalation. Our
team of PhDs and MDs are working to further develop a range of
cannabis-based products, while researching the effect of cannabis
and cannabinoids on health in clinical studies.
Botanicals is proud to be the first Licensed Producer in
Canada to offer THCA
(Tetrahydrocannabinolic acid) oil. THCA is the precursor to
THC and has no psychotropic effects. THCA is isolated from
cannabis through a very gentle extraction process.
"We believe being able to provide our patients with cannabis
oils in a form that can be properly dosed is a big step forward for
Botanicals. Oils, such as THCA, that provide the benefits of
cannabis without a psychotropic effect, should be of great benefit
to our patients and the medical community." stated Dr. Avtar Dhillon, Chairman of
Therapeutics.
ON BEHALF OF THE BOARD
"Dr. Bin Huang"
CEO
Emerald Health Therapeutics Inc.
Therapeutics wholly
owns Botanicals, which has been granted licences under the
Access to Cannabis for Medical Purposes Regulations
(Canada) to cultivate and sell
medical cannabis, and to produce and sell medical cannabis oils in
Canada.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Emerald Health Therapeutics, Inc.